Relationship between FAK and P53 expression in squamous cell carcinomas of the larynx;Relación entre la expresión de FAK y p53 en los carcinomas epidermoides de laringe

Acta Otorrinolaringologica Espanola

Volumn 58, Issue 8, 2007, Pages 347-351

  Rodrigo Tapia, Juan Pablo ^a   Cabanillas, Rubén ^a   Secades, Pablo ^a   Canel, Marta ^a   Chiara, María Dolores ^a   Suárez, Carlos ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

FAK; Larynx; p53; Squamous cell carcinoma

Indexed keywords

FOCAL ADHESION KINASE; PROTEIN P53;

ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER SURGERY; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS;

EID: 35348828599     PISSN: 00016519     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-6519(07)74943-9     Document Type: Article

References (26)

1. Schaller MD, Borgmana CA, Cobb BS, Vines RR, Reynolds AB, Parsons JT. pp125FAK, a structurally unique protein tyrosine kinase associated with focal adhesions. Proc Natl Acad Sci U S A, 1992;89:5192-6.
2. Kornberg L, Earp HS, Parsons JT, Schaller M, Juliano RL. Cell adhesion or integrin clustering increases phosphorylation of a focal adhesion-associated tyrosine kinase. J Biol Chem. 1992;267:23439-42.
3. Sieg DJ, Hauck CR, Ilic D, Klingbeil CK, Schaefer E, Damsky CH, et al. FAK integrates growth factor and integrin signals to promote cell migration. Nat Cell Biol. 2000;2:249-56.
4. Schlaepher DD, Hauck CR, Sieg DJ. Signaling through focal adhesion kinase. Biophys Mol Biol. 1999;71:435-78.
5. Parsons TJ, Martin KH, Slack JK, Taylor JM, Weed SA. Focal adhesion kinase: a regulator of focal adhesion dynamics and cell movement. Oncogene. 2000;19:5606-13.
6. Gabarra-Niecko V, Schaller MD, Dunty JM. FAK regulates biological processes important for the pathogenesis of cancer. Cancer Metastasis Rev. 2003;22:359-74.
7. McLean GW, Carragher NO, Avizienyte E, Evans J, Brunton V, Frame MC. The role of focal-adhesion kinase in cancer- a new therapeutic opportunity. Nature Rev Cancer. 2005;5:505-15.
8. Frisch S M, Vuori K, Ruoslahti E, Chan-Hui PY. Control of adhesion-dependent cell survival by focal adhesion kinase. J Cell Biol. 1996;134:793-9.
9. Schlaepfer DD, Mitra SK, Ilic D. Control of motile and invasive cell phenotypes by focal adhesion kinase. Biochim Biophys Acta. 2004;1692:77-102.
10. Hsia DA, Mitra SK, Hauck CR, Streblow DN, Nelson JA, Ilic D, et al. Differential regulation of cell motility and invasion by FAK. J Cell Biol. 2003;160:753-67.
11. Aguirre Ghiso JA. Inhibition of FAK signalling activated by urokinase receptor induces dormancy in human carcinoma cells in vivo. Oncogene. 2002;21:2513-24.
12. Canel M, Secades P, Rodrigo JP, Cabanillas R, Herrero A, Suárez C, et al. Overexpression of focal adhesion kinase in head and neck squamous cell carcinoma is independent of fak gene copy number. Clin Cancer Res. 2006;12:3272-9.
13. Owens LV, Xu L, Craven RJ, Dent GA, Weiner TM, Kornberg L, et al. Overexpression of the focal adhesion kinase (p125FAK) in invasive human tumours. Cancer Res. 1995;55:2752-5.
14. Cance WG, Harris JE, Iacocca MV, Roche E, Yang X, Chang J, et al. Immunhistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. Clin Cancer Res. 2000;6:2417-23.
15. Recher C, Ysebaert L, Beyne-Rauzy O, Mansat-De Mas V, Ruidavets JB, Cariven P, et al. Expression of focal adhesion kinase in acute myeloid leukemia is associated with enhanced blast migration, increased cellularity, and poor prognosis. Cancer Res. 2004;64:3191-7.
16. Miyazaki T, Kato H, Nakajima M, Sohda M, Fukai Y, Masuda N, et al. FAK overexpression is correlated with tumour invasiveness and lymph node metastasis in oesophageal squamous cell carcinoma. Br J Cancer. 2003;89:140-5.
17. Sood AK, Coffin JE, Schneider GB, Fletcher MS, DeYoung BR, Gruman LM, et al. Biological significance of focal adhesion kinase in ovarian cancer. Role in migration and invasion. Am J Pathol. 2004;165:1087-95.
18. Rodrigo JP, Domínguez F, Suárez V, Canel M, Secades P, Chiara MD. Focal adhesion kinase and E-cadherin as markers for nodal metastasis in laryngeal cancer. Arch Otolaryngol Head Neck Surg. 2007;133:145-50.
19. Golubovskaya V, Kaur A, Cance W. Cloning and characterization of the promoter region of human focal adhesion kinase gene: nuclear factor κB and p53 binding sites. Biochim Biophys Acta. 2004;1678:111-25.
20. Narayana A, Vaughan AT, Gunaratne S, Kathuria S, Walter SA, Reddy SP. Is p53 an independent prognostic factor in patients with laryngeal carcinoma? Cancer. 1998;82:286-91.
21. Couture C, Raybaud-Diogene H, Tetu B, Bairati I, Murry D, Allard J, et al. p53 and Ki-67 as markers of radioresistance in head and neck carcinoma. Cancer. 2002;94:713-22.
22. Golubovskaya VM, Finch R, Cance WG. Direct interaction of the N-terminal domain of focal adhesion kinase with the N-terminal transactivation domain of p53. J Biol Chem. 2005;280:25008-21.
23. Rodrigo JP, Coto E, González MV, Maldonado M, Suárez C. P53 allelic loss and the outcome of patients with squamous cell carcinoma of the head and neck. Eur Arch Otorhinolaryngol. 2001;258:255-8.
24. Cabanillas R, Rodrigo JP, Astudillo A, Domínguez F, Suárez C, Chiara MD. P53 expression in squamous cell carcinomas of the supraglottic larynx and its lymph node metastases: new results for an old question. Cancer. 2007;109:1791-8.
25. Livasy CA, Moore D, Cance WG, Lininger RA. Focal adhesion kinase overexpression in endometrial neoplasia. Appl Immunohistochem Mol Morphol. 2004;12:342-5.
26. Hall PA, Lane DP. P53 in tumor pathology: can we trust immunohistochemistry? Revisited! J Pathol. 1994;172:1-4.